相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bromo-deaza-SAH: A potent and selective DOT1L inhibitor
Wenyu Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
Aniruddha J. Deshpande et al.
BLOOD (2013)
The Pathogenesis of Mixed-Lineage Leukemia
Andrew G. Muntean et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L
Aravind Basavapathruni et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
Synthesis and Structure-Activity Relationship Investigation of Adenosine-Containing Inhibitors of Histone Methyltransferase DOT1L
Justin L. Anglin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Wenyu Yu et al.
NATURE COMMUNICATIONS (2012)
Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation
Stephanie Y. Jo et al.
BLOOD (2011)
DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
Anh Tram Nguyen et al.
BLOOD (2011)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt et al.
CANCER CELL (2011)
MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia
Sara C. Monroe et al.
EXPERIMENTAL HEMATOLOGY (2011)
The diverse functions of Dot1 and H3K79 methylation
Anh Tram Nguyen et al.
GENES & DEVELOPMENT (2011)
Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic Studies
Yuan Yao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes
Debabrata Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Higher-Order Complex Containing AF4 and ENL Family Proteins with P-TEFb Facilitates Oncogenic and Physiologic MLL-Dependent Transcription
Akihiko Yokoyama et al.
CANCER CELL (2010)
MLL-AF9-Induced Leukemogenesis Requires Coexpression of the Wild-Type Mll Allele
Austin T. Thiel et al.
CANCER CELL (2010)
Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
Ming-Jin Chang et al.
CANCER RESEARCH (2010)
Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)
Man Mohan et al.
GENES & DEVELOPMENT (2010)
In Vivo Residue-specific Histone Methylation Dynamics
Barry M. Zee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Kinetics of Re-establishing H3K79 Methylation Marks in Global Human Chromatin
Steve M. M. Sweet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Characterization of the DOT1L Network: Implications of Diverse Roles for DOT1L
Geunyeong Park et al.
PROTEIN JOURNAL (2010)
11q23/MLL Acute Leukemia : Update of Clinical Aspects
Hayato Tamai et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2010)
Misguided Transcriptional Elongation Causes Mixed Lineage Leukemia
Dorothee Mueller et al.
PLOS BIOLOGY (2009)
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Andrei V. Krivtsov et al.
CANCER CELL (2008)
Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia
Matthew G. Guenther et al.
GENES & DEVELOPMENT (2008)
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification
Dorothee Mueller et al.
BLOOD (2007)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling
Emmanuelle Bitoun et al.
HUMAN MOLECULAR GENETICS (2007)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCα in an aldosterone-sensitive manner
Wenzheng Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications
TA Milne et al.
CANCER RESEARCH (2005)
hDOT1L links histone methylation to leukemogenesis
Y Okada et al.
CELL (2005)
MLL: a histone methyltransferase disrupted in leukemia
JL Hess
TRENDS IN MOLECULAR MEDICINE (2004)
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
ER Wood et al.
CANCER RESEARCH (2004)
Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein
PM Ayton et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation
T Nakamura et al.
MOLECULAR CELL (2002)
MLL targets SET domain methyltransferase activity to Hox gene promoters
TA Milne et al.
MOLECULAR CELL (2002)
Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain
Q Feng et al.
CURRENT BIOLOGY (2002)
分享论文
